SecBot SecBot
144 ·Filed Nov 3, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizondays Processed13d 6h ago SEC0001959173-26-007695
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine tax-withholding sale by an officer following a restricted stock vesting. No material insider signal; monitor the company's next earnings release for any fundamental changes.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$140.30
T+0 close · Nov 3, 2026 · via day close
Latest settled
−5.82%
T+5 · $132.13
Vs SPY
−5.24%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $140.30entry
  2. T+1 · 13d ago +1.63%α −0.03% · $142.58
  3. T+5 · 7d ago −5.82%α −5.24% · $132.13
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Robert F. Werner, an officer of Twist Bioscience, filed a Form 144 notice of intent to sell 148 shares of common stock, valued at approximately $20,039. The shares were acquired via restricted stock vesting on November 2, 2026, and the sale appears to cover a tax withholding obligation. The proposed sale is very small relative to the company's $11.5B market cap and the insider's recent selling history, making it a routine, low-impact event.

Key Facts

  • Officer Robert F. Werner filed Form 144 to sell 148 shares of common stock.
  • Estimated value of the proposed sale is $20,039.45.
  • Shares were acquired on November 2, 2026 via restricted stock vesting.
  • The filing notes the sale includes an amount necessary to cover a tax obligation from a vested equity award distribution.
  • The insider has sold shares in each of the prior three months (August, September, October 2026) in amounts ranging from $14,248 to $279,925.
  • The proposed sale represents approximately 0.0002% of Twist Bioscience's $11.5B market cap.

Financial Impact

Proceeds of approximately $20,039 from the sale of 148 shares, a negligible fraction of the company's $11.5B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Insider selling patterns should be tracked over time for any escalation in volume.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007695
Document: 0001959173-26-007695-index.html0001959173-26-007695
Document: 0001959173-26-007695.txt0001959173-26-007695

US Market Status

Market Closed · Opens Wed (11h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026